ANA WILEY: Open Payments
NPI 1750803961 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 58 payments from 14 companies in 2025. Trend: 2023 $863 · 2024 $922 · 2025 $922
Food & beverage: $906Education: $17
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $170 |
| Regeneron Healthcare Solutions, Inc. | 8 | $149 |
| Galderma Laboratories, L.P. | 18 | $141 |
| Incyte Corporation | 4 | $88 |
| GENZYME CORPORATION | 3 | $82 |
| Janssen Biotech, Inc. | 4 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $72 |
| UCB, Inc. | 2 | $34 |
| ConvaTec Inc. | 1 | $25 |
| LNHC, Inc | 1 | $24 |
Products named: DUPIXENT, COSENTYX, NEMLUVIO, OPZELURA, TREMFYA, ILUMYA, Bimzelx, Rhapsido.
Industry payments across VA — which companies pay providers there.
